Biosimilars

Pharmaceutical Industry Outlook 2025: Key Trends and Strategic Priorities | Allcure Remedies

Opening snapshot Pharmaceutical Industry 2025 is the year pharma moves from promise to production: advances in AI and precision science are accelerating R&D, biosimilars are gaining market share as biologic patents expire, and governments and regulators are pushing for stronger manufacturing and supply-chain resilience. At the same time, pricing pressure and evolving policy environments are …

Pharmaceutical Industry Outlook 2025: Key Trends and Strategic Priorities | Allcure Remedies Read More »

The Growth of Biosimilars and Its Implications for Pharma Manufacturing | Allcure Remedies

By Allcure Remedies

5/8/2025 – Chandigarh (Publish by – Allcure Remedies) Introduction The global pharmaceutical landscape is undergoing a seismic shift, with biosimilars emerging as a transformative force. As patents for many blockbuster biologics expire, biosimilars are gaining momentum — offering cost-effective alternatives while maintaining therapeutic efficacy. This evolution is reshaping pharma manufacturing, demanding innovation, flexibility, and stringent …

The Growth of Biosimilars and Its Implications for Pharma Manufacturing | Allcure Remedies Read More »